3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Mesothelioma
17
Mesothelioma, Malignant
15
Solid Tumor
10
Carcinoma, Non-Small-Cell Lung
8
Advanced Solid Tumors
8
Melanoma
6
Carcinoma, Renal Cell
5
Carcinoma, Hepatocellular
5
Advanced Solid Tumor
5
Solid Tumors
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Merkel Cell
3
Advanced or Metastatic Solid Tumors
3
Turcot syndrome
2
Stomach Neoplasms
2
Neoplasm Metastasis
2
Malignant Solid Tumor
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Vinblastine
1
Surveys and Questionnaires
1
Nivolumab
1
Cyclophosphamide
1
Cell- and Tissue-Based Therapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Childhood Solid Tumor
×
Nivolumab
×
Other solid neoplasm
×
Clear all
NCT03585465
2026-05-29
Metro-PD1
Centre Oscar Lambret
Phase 1/2
Terminated
63 enrolled